Interpretable machine learning in predicting drug-induced liver injury among tuberculosis patients: model development
Yue Xiao1, Yanfei Chen1, Ruijian Huang1
1School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu, China.
BMC Medical Research Methodology
|April 20, 2024
Summary
This study developed an interpretable prediction model for drug-induced liver injury (DILI) in tuberculosis (TB) patients. The XGBoost model showed superior performance, identifying key risk factors for DILI.
Area of Science:
- Medical Informatics
- Machine Learning in Healthcare
- Pharmacovigilance
Background:
- Drug-induced liver injury (DILI) is a significant concern during tuberculosis (TB) treatment.
- Predictive models are needed to identify patients at high risk of DILI.
Purpose of the Study:
- To develop and validate an interpretable prediction model for DILI in TB patients.
- To compare the performance of XGBoost, Random Forest, and LASSO logistic models.
Main Methods:
- Utilized a dataset of 7,071 TB patients from Ningbo City.
- Developed and compared XGBoost, RF, and LASSO logistic models.
- Employed SHAP for model interpretability and identified key predictive variables.
Main Results:
- The XGBoost model achieved superior performance with an AUROC of 0.89 and AUPR of 0.75.
- Key predictors for DILI included pre-existing liver conditions (DIH, FLD), age, ALT, and Tbil.
- SHAP analysis elucidated the contribution of these variables to DILI prediction.
Conclusions:
- XGBoost offers improved predictive accuracy for DILI in TB patients compared to RF and LASSO.
- SHAP enhances the clinical interpretability and applicability of the DILI prediction model.
- Further research should focus on external validation and feature integration.
Related Concept Videos
Pulmonary Tuberculosis IV
142
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
142
Pulmonary Tuberculosis I
242
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
242
Pulmonary Tuberculosis V
179
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
179
Pulmonary Tuberculosis III
325
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
325
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
38
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
38
Pulmonary Tuberculosis II
228
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
228


